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OBJECTIVES: To estimate the prevalence of exercise testing alterations in middle-aged women without
symptoms of heart disease and to verify the associations of functional capacity and heart rate behavior during
and after exercise with cardiovascular risk factors.
METHODS: A cross-sectional study was conducted with 509 asymptomatic women aged between 46 and 65 years
who underwent clinical evaluations and exercise testing (Bruce protocol). The heart rate behavior was evaluated
by the maximal predicted heart rate achieved, chronotropic index and recovery heart rate.
RESULTS: The mean age was 56.4±4.8 years, and 13.4% of the patients had a Framingham risk score above 10%.
In the exercise treadmill testing, 58.0% presented one or more of the following alterations (listed in order
of ascending prevalence): symptoms (angina, dyspnea, and dizziness), ST-segment depression, arrhythmia,
reduction in recovery heart rate of p12 bpm at 1 minute, altered maximal predicted heart rate achieved,
abnormal blood pressure, functional capacity deficiency, and altered chronotropic index. In the multivariate
analysis, the following associations (odds ratio) were observed for these alterations: chronotropic index was
associated with obesity (2.08) and smoking (4.47); maximal predicted heart rate achieved was associated with
smoking (6.45); reduction in the recovery heart rate at 1 minute was associated with age (1.09) and obesity
(2.78); functional capacity was associated with age (0.92), an overweight status (2.29) and obesity (6.51).
CONCLUSIONS: More than half of middle-aged women without cardiovascular symptoms present alterations in
one or more exercise testing parameters. Alterations in the functional capacity or heart rate behavior, as verified
by exercise testing, are associated with age, smoking, an overweight status and obesity.
KEYWORDS: Exercise Test; Exercise Tolerance; Women; Middle-Aged.
’ INTRODUCTION
Exercise testing has been used for the prognostic evalua-
tion of general and cardiovascular mortality and following
the occurrence of nonfatal cardiac events (1-5). Among the
parameters of exercise testing, ventricular ectopic beats in
recovery and nonelectrocardiographic parameters, includ-
ing functional capacity, maximal predicted heart rate (HR)
achieved (MPHRA) and HR, are considered predictors of
cardiovascular mortality (3-6).
The relevance of functional capacity as a predictor of fatal
cardiovascular events was verified in cohort studies per-
formed exclusively with the female sex (7-9). Regarding the
HR behavior in the exercise testing, an abnormal response at
peak or at recovery is also considered a predictor of death,
regardless of the Framingham risk score (7,10,11). These
findings are highlighted in the guidelines for exercise testing
from various scientific societies (1,2-6,12-14).
In asymptomatic women, the prognostic value of these non-
electrocardiographic parameters of exercise testing (4,7,8,15)DOI: 10.6061/clinics/2019/e1005
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may support their use in clinical practice and in primary
prevention programs since they add value to traditional
cardiovascular risk scores. This contribution is particularly
relevant for middle-aged women due to an important change
in the cardiovascular risk profile related to estrogen deficiency
and due to the high prevalence of smoking, obesity, dysli-
pidemias, diabetes and hypertension (16,17).
However, the prevalence of alterations in the nonelectro-
cardiographic parameters of exercise testing that serve as
predictors of mortality and their associations with cardio-
vascular risk factors are still poorly studied in middle-aged
women. In general, studies (7-11,15) that investigate the
association of functional capacity and HR behavior during
and after exercise with other variables use fatal cardiovas-
cular events as the outcome. Moreover, the parameters of
exercise testing that can serve as predictors of cardiovascu-
lar events are not always explicit in the results of the
examination and are therefore not used in clinical practice.
Thus, the present study aims to estimate the prevalence of
alterations in exercise testing in middle-aged asympto-
matic women and to verify the association of functional
capacity and HR behavior with traditional cardiovascular
risk factors.
’ METHODS
A cross-sectional study was carried out in middle-aged
women, and this project was approved by the Ethics
Committee of the institution where the data were collected
(CAAE 0159.0.106.106-11). Participants signed a Free and
Informed Consent Term form, and specialized follow-up
was offered to women who presented significant alterations
in the exercise testing, such as limiting angina, ischemic
depression and complex arrhythmia.
Sample and data collection
A total of 509 women who were aged 46-65 years and
did not have cardiovascular symptoms were selected from
two outpatient services for women. The exclusion criteria
included the following: a history of referred or clinically evi-
dent cardiovascular disease, except systemic arterial hyper-
tension; a diagnosis of liver or kidney disease; the use of
corticosteroids or hormone replacement therapy; pregnancy;
the use of an intrauterine device; the use of hormonal con-
traceptives in the past year; and contraindications to exercise
testing according to the III Guideline on Exercise Testing of
the Brazilian Society of Cardiology (1).
A structured questionnaire was used to evaluate variables
related to cardiovascular risk factors, which included the
woman’s history, the use of specific medications, clinical
examinations and biochemical tests. The body mass index
(BMI=weight/height2) was used to classify women into three
categories: eutrophic (o24.9 kg/m2), overweight (25-29.9
kg/m2) and obese (430 kg/m2). Exercise testing was per-
formed by the principal investigator following the Bruce
protocol (18) (Inbrameds treadmill with the ErgoPcs
exercise testing program and a Unitecs mercury column
tensiometer); testing was discontinued by a threshold symp-
tom criterion, which was generally muscle and/or respira-
tory fatigue. The interpretation of the results of the exercise
testing were based on the parameters established by the
Brazilian Society of Cardiology (1).
To examine the variables of the exercise testing considered
predictors of mortality (3,4,15), the following formulas were
used: (a) functional capacity = (maximum VO2 reached x
100)/VO2 predicted, where the predicted VO2 = 14.7 - (0.13 x
age); (b) MPHRA = peak HR x 100/predicted HR; (c)
chronotropic index = (peak HR - resting HR) x 100/
(predicted HR - resting HR). To estimate the MPHRA and
chronotropic index, the predicted HR = (220 - age), as
recommended by Karnoven et al. (19); and (d) reduction
in recovery HR at 1 minute = peak HR - recovery HR at
1 minute. The HR behavior was evaluated by the MPHRA,
chronotropic index and recovery HR. According to previous
reports (3,4,13), the cutoff value of functional capacity was
considered to be less than 85%; the cutoff for the reduction in
recovery HR at 1 minute was equal to or less than 12 bpm;
the cutoff for the MPHRA was less than 85%; and the cutoff
for chronotropic index was below 80%. For the last two
variables, in women taking HR-lowering medication, values
below 62% were classified as altered (3,4,6).
Statistical analysis
For continuous variables, the data is described by the
mean and dispersion measurements (standard deviation and
the minimum and maximum values). The normality of the
distribution was verified by the Komogorov-Smirnov test.
For categorical variables, the absolute and relative frequency
distributions are shown. The prevalence of alterations in the
variables evaluated in the exercise testing was calculated,
and 95% confidence intervals (CIs) are presented.
In the analysis of the associations between functional
capacity and HR behavior with cardiovascular risk factors,
the association measures of the odds ratio (OR) and the 95%
CI were calculated. In the final modeling, a multivariate
logistic regression technique with a stepwise method was
used that included variables that were statistically significant
in the bivariate analysis (below 20%; po0.2). Statistically
significant variables (below 10%; po0.1) were maintained in
the model. A database was built in the Microsoft Office Access
program, and data were analyzed in the Stata program
(version 12.0).
’ RESULTS
The study sample, as shown in Table 1, consisted of 509
women with a mean age of 56.4±4.8 years, of whom 11.2%
were diabetic patients and 13.4% had a Framingham risk
score above 10%. This table also includes the descriptive
measures of exercise testing variables, including peak HR
and recovery HR at 1 minute, including the mean when
appropriate. In only 15 (3.1%) women, the exercise testing
was interrupted before the women reached fatigue, most
frequently for reasons unrelated to the cardiovascular system
(vestibular syndrome, orthopedic limitations, and treadmill
maladaptation). The exercise was interrupted in three women
due to limiting chest pain and dyspnea that were compatible
with myocardial ischemia. One of the patients had ischemic
ST changes associated with ventricular tachycardia and
underwent cardiac catheterization and percutaneous cor-
onary intervention.
The prevalence of alterations in exercise testing (Table 2)
varied between 2.2% (the presence of symptoms: angina,
dyspnea, and dizziness) and 27.7% (altered chronotropic
index). Of the 22 (4.3% of all women) patients with ST
depression, eleven (2.2%) presented a depression equal to
or greater than one millimeter, with a horizontal or descend-
ing pattern. These women were referred for specialized
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follow-ups. Alterations in one or more variables were
observed in 27.9% of the women, who presented with
symptoms, arrhythmia, ST-segment depression and/or
abnormal blood pressure. On the other hand, 44.0% presented
alterations in one or more of the four nonelectrocardiographic
variables predicting mortality. One or more alterations in these
eight parameters were identified in 58.0% of the women.
In the bivariate analysis (Table 3), the following associa-
tions between alterations in the nonelectrocardiographic
variables predicting mortality and cardiovascular risk factors
were identified: (a) chronotropic index was associated with
obesity, hypertension and smoking; (b) MPHRA was asso-
ciated with smoking; (c) reduction in recovery HR at 1 minute
was associated with age, BMI, obesity, hypertension and three
or four cardiovascular risk factors; and (d) functional capacity
was associated with age, age from 55-60 years and 61-65
years, BMI, an overweight status and obesity.
In the multivariate analysis (Table 4), the following
associations remained: chronotropic index with obesity
(OR=2.08) and smoking (OR=4.47); altered MPHRA with
smoking (OR=6.45); mild reduction in recovery HR at
1 minute with age (OR=1.09) and obesity (OR=2.78); alteration
in functional capacity with age (OR=0.92), an overweight
status (OR=2.29) and obesity (OR=6.51). Obesity was asso-
ciated with the highest number of predictive variables that
were altered in the exercise testing and, together with
smoking, presented the highest risk.
’ DISCUSSION
The present study found that more than half of the middle-
aged women in the sample, who had no previous cardio-
vascular symptoms, had one or more altered parameters in
exercise testing. The presence of symptoms and the depres-
sion of the ST segment occurred less frequently, and alter-
ations in the nonelectrocardiographic variables predicting
mortality, especially chronotropic index and functional capa-
city, were observed more frequently. The study also showed
that alterations in functional capacity or HR behavior in
exercise testing are associated with age, smoking, an over-
weight status and obesity.
Table 1 - Baseline characteristics of the sample and the exercise
testing.
Characteristics Statistics (n = 509)
Age (years)* 56.4±4.8 (46-65)
BMI (kg/m2)* 27.8±4.9 (14.8-42.1)
Age group (years) (n,%)
46-50 62 (12.2%)
51-55 175 (34.4%)
56-60 149 (29.3%)
61-65 123 (24.2%)
Clinical history (n, %)
Diabetes 57 (11.2%)
Systemic arterial hypertension 247 (48.5%)
Dyslipidemia 211 (41.5%)
Obesity 158 (31.0%)
Smoking 39 (7.7%)
Use of b-blockers 57 (11.2%)
Number of cardiovascular risk factorsw (n, %)
None 125 (24.6%)
One 157 (30.8%)
Two 138 (27.1%)
Three or more 89 (17.5%)
Framingham risk score= (n,%)
o5% 409 (80.3%)
5 to 10% 32 (6.3%)
410% 68 (13.4%)
Exercise testing*
Resting HR (bpm) 74.4±13.3 (37-136)
Resting SBP (mm Hg) 138.4±18.1 (90.0-210.0)
Resting DBP (mm Hg) 85.1±8.9 (50.0-125.0)
Peak HR (bpm) 152.4±19.6 (79-200)
Recovery HR at 1 minute (bpm) 130.7±19.3 (69-183)
Functional capacity (VO2/METs) 7.6±2.0 (1.5-14.7)
MPHRA 93.2±11.5 (50.3-122.7)
Chronotropic index 88.4±20.8 (17.0-155.6)
Reduction in recovery HR at 1 minute 21.8±9.1 (-2-76)
Percent of the functional capacity reached
relative to the estimated functional
capacity
104.9±26.9 (23.8-230.5)
BMI – Body mass index; HR – Heart rate; SBP – Systolic blood pressure;
DBP – Diastolic blood pressure; MPHRA – Maximal predicted heart rate
achieved.
*Average ± standard deviation (minimum value - maximum value);
wCardiovascular risk factors: diabetes, systemic arterial hypertension,
dyslipidemia, obesity and smoking; =Women with diabetes were classified
as having a Framingham risk score 410%.
Table 2 - Prevalence of alterations in the exercise testing variables in middle-aged asymptomatic women.
Exercise testing Prevalence
N (%) 95% CI
Parameters evaluated
Symptoms (angina, dyspnea, and dizziness) 11 (2.2%) 1.2%-3.8%
Abnormal blood pressure 93 (18.3%) 15.2%-21.9%
Arrhythmia 43 (8.4%) 6.3%-11.2%
ST depression 22 (4.3%) 2.9%-6.5%
MPHRAo85%* 73 (14.3%) 11.2%-17.2%
Chronotropic index o80% 141 (27.7%) 23.8%-31.5%
Reduction in recovery HR at 1 minute p12 bpm 69 (13.6%) 10.8%-16.8%
Percent of functional capacity reached relative to the estimated o85% functional capacity 118 (23.2%) 19.5%-26.9%
Change in one or more parameters
Symptoms, arrhythmia and/or ST depression 67 (13.2%) 10.5%-16.4%
Symptoms, arrhythmia, ST depression and/or abnormal blood pressure 142 (27.9%) 24.2%-32.0%
MPHRA o85%, chronotropic index o80%, reduction in recovery HR of p12 bpm at 1 minute
and/or altered functional capacity
224 (44.0%) 39.9%-48.6%
One or more of the eight evaluated parameters altered 295 (58.0%) 53.6%-62.2%
MPHRA – Maximal predicted heart rate achieved; HR – Heart rate.
*MPHRA and chronotropic index o62% were considered altered in women (n=57) using b-blockers.
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The prevalence of alterations in exercise testing variables
observed in this study differs from those in asymptomatic
women with a similar mean age that were described by some
authors (8,15,20-22). Here, a lower prevalence was observed
than that described by other authors for ST-segment depres-
sion (8,20-22), reduction in recovery HR of p12 bpm at
1 minute (22) and the proportion of functional capacity
attained in relation to the estimated value for functional
capacity o85% (15). On the other hand, the prevalence of
MPHRAo85% (20) and chronotropic indexo80% was higher
here than in other studies (15,20).
Demographic characteristics, cardiovascular risk factors,
reasons for the interruption of the exam and formulas used
to calculate the predictors of mortality should be taken into
account when comparing the prevalence of exercise testing
alterations (11,21,23). In this study, exercise testing interrup-
tions were symptom-limited. The interruption by estimated
HR without fatigue results in a higher prevalence of altered
functional capacity. Regarding the formulas used to determine
the MPHRA and chronotropic index, the equation that is
traditionally used (= 220 - age) (19) was used to calculate the
maximum estimated HR; however, some studies used other
calculation methods (11,20,21), which resulted in a different
prevalence of alterations for these predictive variables. In
this regard, in middle-aged women, Gulati et al. (1) observed
that the prevalence of an MPHRA o85% and a chronotropic
index o80% that were observed when using the traditional
calculation of the estimated HR were, respectively, 2.3 and
1.9 times higher than those obtained from another formula
[= 206 - (0.88 x age)].
Regarding the associations that were studied, the use
of functional capacity and the HR response as the main
outcomes are supported. In general, these nonelectrocar-
diographic variables of exercise testing are used in mul-
tivariate analyses as independent variables to examine the
associations with acute myocardial infarction and death
(7-11,21,22,24,25). Nevertheless, in the initial stage of some
studies (11,24,25) that verified the predictive value of the
nonelectrocardiographic variables of the exercise testing for
mortality, the bivariate associations between functional capa-
city, chronotropic response, chronotropic index and reduction
in recovery HR at 1 minute with age, sex, BMI, systemic
arterial hypertension, smoking, dyslipidemias, diabetes and
other cardiovascular risk factors were evaluated.
The bivariate associations of the MPHRA with smoking
and a reduction in the recovery HR of p12 at 1 minute with
age and hypertension that were observed in this study were
also identified by Maddox et al. (24). However, unlike the
present study, these authors (24) also observed bivariate
associations of these variables with diabetes and dyslipidemia.
Bivariate associations between a chronotropic index of less
than 80% and obesity, hypertension and smoking were
observed in this study and were also found in a cohort of st.
James (11). More recently, similar to the findings of the present
study, Abdelmoneim et al. (20) did not observe a bivariate
association of chronotropic index with diabetes and dyslipi-
demia. Regarding functional capacity o85%, in agreement
with Peterson et al. (26), a bivariate association of this variable
with age and obesity was identified. However, in this
study, there were no associations with smoking, diabetes
and hypertension, as verified by other authors (26). The
multivariate analysis highlighted that obesity represented
the main risk association for low functional capacity and a
mild reduction in recovery HR at 1 minute in the present
study. Smoking was the main factor associated with the
MPHRA and chronotropic index. Therefore, the significant
association of the variables of exercise testing predicting
mortality with obesity and smoking should be emphasized.
These factors, together with low functional capacity, can be
modified by preventive actions.
The discrete protective association of advancing age for
functional capacity was an unexpected finding, and it is
possible that other variables that were not tested, such as
regular physical activity and the specialized follow-up for
the women of the sample with greater age, influenced this
result. A limitation of this study was that because it was a
cross-sectional study, it is important to test the associations
that were observed in a longitudinal study. In addition, the
sample studied was drawn from specialized public services,
which restricts the extrapolation of these results to the gene-
ral population.
In this study, the sample was composed of middle-aged
women who have less representation in this type of study
and in large clinical trials worldwide (27). In clinical practice,
there are fewer requests for exercise testing for middle-aged
women, suggesting that the minimum parameters are not
optimized and that there is a high prevalence of false
positives in this group (28). In the present study, an adequate
number of participants achieved the average parameters for
exercise time and maximum HR, and there was a low pre-
valence of ST alterations, which allowed the appropriate
interpretation of this test.
It should be emphasized that the exercise testing variables
related to functional capacity and the HR behavior at the
peak and after the peak, which were included in the present
study, are not always valued in the clinical interpretation
of exercise testing despite their importance as predictors of
mortality. Supporting the importance of these factors, a large
trial (29) with low-risk women with suspected coronary
artery disease showed no difference in exercise testing with
Table 4 - Multivariate analysis of alterations in the predictive variables of exercise testing with cardiovascular risk factors in middle-
aged asymptomatic women.
Variables Alterations in exercise testing
Chronotropic index MPHRA Reduction in recovery HR at 1 minute Percent of functional capacity
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
Age (years) 1.09 (1.03-1.15) 0.003 0.92 (0.88-0.97) 0.001
Eutrophic 1.0 - 1.0 - 1.0 -
Overweight 1.10 (0.66-1.83) 0.717 1.89 (0.92-3.87) 0.083 2.29 (1.21-4.33) 0.011
Obese 2.08 (1.24-3.47) 0.005 2.78 (1.35-5.71) 0.005 6.51 (3.52-12.0) o0.001
Smoking 4.47 (2.24-8.90) o0.001 6.45 (3.24-12.8) o0.001
MPHRA – Maximal predicted heart rate achieved; HR – Heart rate.
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or without myocardial scintigraphy in the prediction of two-
year survival. In addition, exercise testing alone was more
cost-effective. The lack of exposure to radiation and the logistic
ease of exercise testing should be considered, especially in
countries such as Brazil, with technological inequalities and
limited health resources.
The present study supports the use of exercise testing
in middle-aged women by using a symptom-limited Bruce
protocol, with the evaluation of variables considered pre-
dictors of mortality, to identify women who need follow-up
with other investigations. Therefore, these findings support
exercise testing in the routine investigation of middle-aged
women, as well as the inclusion of this test in programs for the
prevention of cardiovascular events and health promotion.
In summary, one or more alterations in exercise testing
related to functional capacity, HR behavior, the presence of
symptoms, and electrocardiographic and blood pressure
abnormalities were observed in more than half of the tested
middle-aged women who are had no cardiovascular symp-
toms and no known heart disease. Alterations in functional
capacity or HR behavior, as verified by exercise testing, are
associated with age, smoking, an overweight status and
obesity.
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